Christine Wiltshire Sekaggya (Christine Sekaggya-Wiltshire)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 9

Top Venues

medRxiv : the preprint server for health sciences

African journal of laboratory medicine

Journal of the International AIDS Society

JMIR research protocols

Makerere University Infectious Diseases Institute

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Makerere University Infectious Diseases Institute Sep 01 2012

Uganda

Research Fellow :: Research

Publications

Christine Wiltshire Sekaggya, Irene Mbabazi, Ruth Nabisere-Arinaitwe, Grace Banturaki, Lucy Alinaitwe, Brian Otalo, Florence Aber, Juliet Nampala, Rogers Owor, Josephine Bayiga, Eva Laker Agnes Odongpiny, Barbara Castelnuovo, Jonathan Mayito, Moorine Sekadde, Jotam G Pasipanodya, Stavia Turyahabwe, Stella Zawedde-Muyanja
Clinical Predictors of 3-Months Isoniazid Rifapentine (3HP) - Related Adverse Drug Reactions (ADR) During Tuberculosis Preventive Therapy. (PAnDoRA-3HP study): An Observational Study Protocol. medRxiv : the preprint server for health sciences (2024)
Christine Wiltshire Sekaggya, Irene Mbabazi, Ruth Nabisere-Arinaitwe, Grace Banturaki, Lucy Alinaitwe, Brian Otalo, Florence Aber, Juliet Nampala, Rogers Owor, Josephine Bayiga, Eva Laker Agnes Odongpiny, Barbara Castelnuovo, Jonathan Mayito, Moorine Sekadde, Jotam G Pasipanodya, Stavia Turyahabwe, Stella Zawedde-Muyanja
Clinical Predictors of 3-Months Isoniazid Rifapentine (3HP) - Related Adverse Drug Reactions (ADR) During Tuberculosis Preventive Therapy. (PAnDoRA-3HP study): An Observational Study Protocol. medRxiv : the preprint server for health sciences (2024)
Christine Wiltshire Sekaggya, Irene Mbabazi, Ruth Nabisere-Arinaitwe, Grace Banturaki, Lucy Alinaitwe, Brian Otalo, Florence Aber, Juliet Nampala, Rogers Owor, Josephine Bayiga, Eva Laker Agnes Odongpiny, Barbara Castelnuovo, Jonathan Mayito, Moorine Sekadde, Jotam G Pasipanodya, Stavia Turyahabwe, Stella Zawedde-Muyanja
Clinical Predictors of 3-Months Isoniazid Rifapentine (3HP) - Related Adverse Drug Reactions (ADR) During Tuberculosis Preventive Therapy. (PAnDoRA-3HP study): An Observational Study Protocol. medRxiv : the preprint server for health sciences (2024)
Denis Omali, Allan Buzibye, Richard Kwizera, Pauline Byakika-Kibwika, Rhoda Namakula, Joshua Matovu, Olive Mbabazi, Emmanuel Mande, Christine Wiltshire Sekaggya, Damalie Nakanjako, Ursula Gutteck, Keith P W J McAdam, Philippa Easterbrook, Andrew Kambugu, Jan S Fehr, Castelnuovo Barbara, Yukari C Manabe, Mohammed Lamorde, Daniel Mueller, Concepta Merry
Building clinical pharmacology laboratory capacity in low- and middle-income countries: Experience from Uganda. African journal of laboratory medicine 12 (1) (2023)
Denis Omali, Allan Buzibye, Richard Kwizera, Pauline Byakika-Kibwika, Rhoda Namakula, Joshua Matovu, Olive Mbabazi, Emmanuel Mande, Christine Wiltshire Sekaggya, Damalie Nakanjako, Ursula Gutteck, Keith P W J McAdam, Philippa Easterbrook, Andrew Kambugu, Jan S Fehr, Castelnuovo Barbara, Yukari C Manabe, Mohammed Lamorde, Daniel Mueller, Concepta Merry
Building clinical pharmacology laboratory capacity in low- and middle-income countries: Experience from Uganda. African journal of laboratory medicine 12 (1) (2023)
Andrea L Jorgensen, Catherine Orrell, Catriona Waitt, Cheng-Hock Toh, Christine Wiltshire Sekaggya, Dyfrig A Hughes, Elizabeth Allen, Emmy Okello, Gayle Tatz, Giovanna Culeddu, Innocent Gerald Asiimwe, Jerome Roy Semakula, Johannes P Mouton, Karen Cohen, Marc Blockman, Mohammed Lamorde, Munir Pirmohamed
A "Bundle of Care" to Improve Anticoagulation Control in Patients Receiving Warfarin in Uganda and South Africa: Protocol for an Implementation Study. JMIR research protocols 12 (2023)
Matthew L Romo, Ellen Brazier, Dominique Mahambou-Nsondé, Reneé De Waal, Christine Wiltshire Sekaggya, Cleophas Chimbetete, Winnie R Muyindike, Gad Murenzi, Cordelia Kunzekwenyika, Thierry Tiendrebeogo, Josephine A Muhairwe, Patricia Lelo, Anastase Dzudie, Christella Twizere, Idiovino Rafael, Oliver Chukwujekwu Ezechi, Lameck Diero, Marcel Yotebieng, Lukas Fenner, Kara K Wools-Kaloustian, N Sarita Shah, Denis Nash, null null
Real-world use and outcomes of dolutegravir-containing antiretroviral therapy in HIV and tuberculosis co-infection: a site survey and cohort study in sub-Saharan Africa. Journal of the International AIDS Society 25 (7) (2022)
Innocent Gerald Asiimwe, Daniel Kiiza, Stephen Ian Walimbwa, Christine Wiltshire Sekaggya
Genetic factors associated with tuberculosis-related clinical outcomes in HIV-infected Black African patients: a systematic review and meta-analysis. Pharmacogenomics 22 (15) (2021)
Ruth Nabisere, Joseph Musaazi, Paolo Denti, Florence Aber, Mohammed Lamorde, Kelly E Dooley, Rob Aarnoutse, Derek J Sloan, Christine Wiltshire Sekaggya
Pharmacokinetics, SAfety/tolerability, and EFficacy of high-dose RIFampicin in tuberculosis-HIV co-infected patients on efavirenz- or dolutegravir-based antiretroviral therapy: study protocol for an open-label, phase II clinical trial (SAEFRIF). Trials 21 (1) (2020)

Christine Wiltshire Sekaggya.css-eqlu8i{font-size:small;padding-left:4px;} (Christine Sekaggya-Wiltshire)

Publication Activity (10 Years)

Top Topics

Top Venues

Christine Wiltshire Sekaggya (Christine Sekaggya-Wiltshire)